National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 564 cases where Vaccine is RV1 and Symptom is Intussusception and Appearance Date from '2008-02-01' to '2014-12-31'

Table

   
AgeCountPercent
< 3 Years55297.87%
3-6 Years10.18%
Unknown111.95%
TOTAL564100%

Case Details

This is page 1 out of 57

Result pages: 1 2 3 4 5 6 7 8 9 10   next


VAERS ID: 331912 (history)  
Age: 0.5  
Gender: Female  
Location: Oregon  
Vaccinated:2008-10-30
Onset:2008-11-05
   Days after vaccination:6
Submitted: 2008-11-10
   Days after onset:5
Entered: 2008-11-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX) / GLAXOSMITHKLINE BIOLOGICALS AC21B192CA / 2 LL / IM
HIBV: HIB (ACTHIB) / SANOFI PASTEUR UF505AB / 2 LL / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH UNKNOWN / 2 RL / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41FA692A / 0 - / PO

Administered by: Unknown       Purchased by: Unknown
Symptoms: Enema administration, Intussusception, Surgery, Urinary system X-ray
SMQs:, Gastrointestinal obstruction (narrow)

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none. PMH: none
Diagnostic Lab Data: KUB/contrast enemas. Labs and Diagnostics: Air contrast enema (+) for IS. Abd X-ray c/w IS. HCT 31.5. Hgb 10.4. Platelets 15.2K.
CDC Split Type:

Write-up: Intussusception - symptoms started 11/5/08; confirmed by x-ray on 11/6/08; unable to reduce by air contrast and barium contrast; required air transport to tertiary hospital and subsequent surgery. 11/18/2008 D/C Summary recieved for DOS 11/17-19/2008 with Final DX: Intussusception-ileocolic. Pt initially presented with pain, moaning, vomiting and blood streaked stool. Pt presented to hospital from another facility following failed reduction of IS via air contrast barium enema. Again, uanable to reduce so taken to OR for Laparoscopic reduction. Pt tolerated well, diet advance and d/c 11/9/08.


VAERS ID: 332276 (history)  
Age: 0.2  
Gender: Male  
Location: Missouri  
Vaccinated:2008-10-03
Onset:2008-10-26
   Days after vaccination:23
Submitted: 2008-11-13
   Days after onset:18
Entered: 2008-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX) / GLAXOSMITHKLINE BIOLOGICALS AC21B138BA / 0 UN / UN
HIBV: HIB (ACTHIB) / SANOFI PASTEUR UF450AB / 0 UN / UN
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH C86141 / 0 UN / UN
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA691A / 0 - / PO

Administered by: Public       Purchased by: Public
Symptoms: Intussusception
SMQs:, Gastrointestinal obstruction (narrow)

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: No concurrent medication
Current Illness: Unknown
Preexisting Conditions: There was no history of adverse events following previous vaccinations as this was the subjects first set of vaccinations. PMH: none.
Diagnostic Lab Data: Unk. Labs and diagnostics: Air contrast enema (+) for IS in proximal transverse colon. Abd US (+) for ileocolic IS. Abd X-ray c/w bowel obstruction.
CDC Split Type: A0755882A

Write-up: This case was reported by a healthcare professional and described the occurrence of intussusception in a 9-week-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent vaccination included ACTHIB (Sanofi), PEDIARIX (GlaxoSmithKline) and PREVENAR (Lederle) all given on 3 October 2008. There were no concurrent medications. On 3 October 2008 at 12:00 the subject received 1st dose of ROTARIX (oral). On 26 October 2008, 23 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalised and the healthcare professional considered the event was disabling, life threatening and clinically significant (or requiring intervention). The subject was treated with unknown (Unknown treatment). On 6 November 2008, the event was resolved. The healthcare professional considered the event was probably related to vaccination with ROTARIX. 12/01/2008 MR received for DOS 10/26-30/2008 with D/C DX: Intussusception. Pt presented with 4 day hx of fussiness, intermittent emesis, tarry stool and poor po intake. IS noted on Abd US with attempted air enema reduction which was unsuccessful x 3. Taken to OR for an open reduction of IS, appendectomy and repair of serosal tears. initially NPO with PCA pain mgmt. Transitioned to oral diet and pain meds and d/c on POD#3.


VAERS ID: 341136 (history)  
Age: 0.2  
Gender: Female  
Location: California  
Vaccinated:2009-01-20
Onset:2009-01-24
   Days after vaccination:4
Submitted: 2009-03-03
   Days after onset:38
Entered: 2009-03-05
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR C3000AA / - UN / UN
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41FA798A / 0 - / PO

Administered by: Private       Purchased by: Private
Symptoms: Enema administration, Intussusception
SMQs:, Gastrointestinal obstruction (narrow)

Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: The subject had no concomitant medications.
Current Illness: Unknown
Preexisting Conditions: The subject had no concomitant medications, relevant medical history or adverse events following previous vaccinations. PMH: 32 wk premie
Diagnostic Lab Data: UNK. Labs and Diagnostics: Abd X-ray (+) for dilated bowel loops. BE (+) for persistant filling defect. Abd US c/w IS. Stool heme (+).
CDC Split Type: A0767773A

Write-up: This case was reported by a physician and described the occurrence of intussusception in a 3-month-old female subject who was vaccinated with ROTARIX. The subject had no concomitant medications, relevant medical history or adverse events following previous vaccinations. Previous and/or concurrent vaccination included DAPTACEL; Sanofi given on an 20 January 2009. On 20 January 2009 the subject received 1st dose of ROTARIX (1ml, oral). On 24 January 2009, 4 days after vaccination with ROTARIX, the subject experienced intussusception. It was attempted to resolve the intussusception with enemas twice and then the subject did have to undergo bowel surgery. The subject was in the hospital for four to five days and has since been released. The physician saw the subject on 02 February 2009 and stated that the subject was "recovering nicely". The physician did not think he will use ROTARIX again. The physician considered the event was disabling, life threatening and clinically significant (or requiring intervention). At the time of reporting the event was improved. The physician considered the event was probably related to vaccination with ROTARIX. 4/13/09 MR received for DOS 1/25-28/2009 with d/C DX: Intussusception of intestine. Pt presented with 2 day hx of emesis, bloody stool and lethargy with intermittent fussiness. PE (+) for abd distention. IS dx by US. Attempted reduction by BE only partially successful. Unable to fully reduce so pt to OR for Ex lap with reduction of IS and incidental appy. Improved on d/c.


VAERS ID: 344235 (history)  
Age: 0.2  
Gender: Female  
Location: New York  
Vaccinated:2009-03-31
Onset:2009-04-13
   Days after vaccination:13
Submitted: 2009-04-15
   Days after onset:2
Entered: 2009-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX) / GLAXOSMITHKLINE BIOLOGICALS AC21B207AA / 0 LL / IM
HIBV: HIB (ACTHIB) / SANOFI PASTEUR UF513AA / 0 RL / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D33245 / 0 LL / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41FA697A / 0 - / PO

Administered by: Private       Purchased by: Private
Symptoms: Abdominal X-ray, Enema administration, Exploratory operation, Intussusception, Lethargy, Surgery, Vomiting, X-ray with contrast upper gastrointestinal tract
SMQs:, Acute pancreatitis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal obstruction (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypoglycaemia (broad)

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: Hospitalized 2/13/09; RSV; Bronchiolitis
Diagnostic Lab Data: Abdominal series; UGI; air contrast enema; exploratory surgery 5/14/09 hospital discharge summary recieved DOA 4/9/09-4/13/09. LABS and DIAGNOSTICS: Abdominal x-ray - dilated small bowel loops. Air contrast enema. CT scan of abdomen/pelvis - thickened bowel and free fluid. Exploratory laparotomy - already reduced intussusception, ileocecal valve edematous.
CDC Split Type:

Write-up: Pt. received vaccine 3/31/09. Presented with vomiting, lethargy on 4/14/09. Required surgery for Intussusception. 5/14/09 hospital discharge summary recieved DOA 4/9/09-4/13/09. FINAL DIAGNOSIS: Intussusception Post vaccination emesis, abdominal distention, lethargic, blood clots around anus.


VAERS ID: 346278 (history)  
Age: 0.3  
Gender: Female  
Location: South Carolina  
Vaccinated:2009-04-03
Onset:2009-05-10
   Days after vaccination:37
Submitted: 2009-05-13
   Days after onset:3
Entered: 2009-05-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX) / GLAXOSMITHKLINE BIOLOGICALS AC21B207AA / - RL / IM
HIBV: HIB (ACTHIB) / SANOFI PASTEUR UF595AA / - LL / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH C87338 / - LL / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41FA697A / - - / PO

Administered by: Unknown       Purchased by: Unknown
Symptoms: Abdominal mass, Bowel movement irregularity, Gastritis, Haematochezia, Intestinal resection, Intussusception, Pyrexia, Vomiting
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Gastrointestinal obstruction (narrow), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific inflammation (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Noninfectious diarrhoea (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: no
Current Illness: no
Preexisting Conditions: newborn jaundice
Diagnostic Lab Data: 6/15/09 Hospital records received DOS 5/12/09. LABS and DIAGNOSTICS: Reduction of intussusception with air contrast enema unsuccessful.
CDC Split Type:

Write-up: Pt seen in hospital on May 11, 2009 with bilious emesis, and low grade fever. She was sent home with the diagnosis of acute gastritis. The patient presented to our clinic on Tuesday morning with same complaint and also report of no bowel movement for three days. When Dr. examined baby she had a palpable mass in her left lower abdomen. He then noted after examining her rectum, a grossly bloody stool. Patient was then sent to hospital where she was diagnosed with intussusception. She underwent bowel resection oon May 12, 2009. 6/15/09 Hospital records received DOS 5/12/09. Assessment: Intussusception. Patient presented with abdominal pain, bilious vomiting, crying, blood per rectum, bloody stool, fussy, lethargic. Congestion past 24hrs. Decreased skin turgidity. Tachycardia.6/22/09-ICD-9 codes received 560.0, 787.03. V 641. 9/28/09 Discharge summary received for date of service 5/12/09 to 5/17/09 DX: Successful surgical open reduction of the intussusception


VAERS ID: 349618 (history)  
Age: 0.4  
Gender: Male  
Location: Alabama  
Vaccinated:2009-05-27
Onset:2009-06-04
   Days after vaccination:8
Submitted: 2009-06-19
   Days after onset:15
Entered: 2009-06-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (PENTACEL) / SANOFI PASTEUR C3230AA / 1 LL / UN
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D37016 / 1 LL / UN
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41SA697A / 1 - / PO

Administered by: Private       Purchased by: Public
Symptoms: Intussusception
SMQs:, Gastrointestinal obstruction (narrow)

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: The subject was completely healthy prior to vaccination. He had not experienced adverse events following prior vaccinations.
Diagnostic Lab Data: UNK. 7/9/09 Hospital records received DOS 6/5/09 to 6/7/09. LABS and DIAGNOSTICS: Hemoccult (+). X-ray Chest / Abdomen - multiple dilated loops of bowel. Abdominal Ultrasound - intussusception.
CDC Split Type: A0792059A

Write-up: This case was reported by a physician, via a GSK representative and described the occurrence of intussusception in a 4-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). The subject was completely healthy prior to vaccination. He had not experienced adverse events following prior vaccinations. Concurrent vaccinations included PENTACEL (non-GSK) (Sanofi) given on 27 May 2009; PREVNAR (Wyeth Labs) given on 27 May 2009. On 27 May 2009 the subject received 2nd dose of ROTARIX (1 ml, oral). The lot number was reported as "A41SA697A". On 4 June 2009, 8 days after vaccination with ROTARIX, the subject experienced intussusception. The subject was hospitalized for 4 days and the physician considered the event was disabling, life threatening and clinically significant (or requiring intervention). The subject was treated with intravenous fluids and barium enema. On 8 June 2009, the event was resolved. 7/9/09 Hospital records received DOS 6/5/09 to 6/7/09. Assessment: Intussusception. Patient presented with vomiting and has not tolerated any po intake. Prior ER visits. Restless, cries, screams. Appears uncomfortable, listless, abdomen tender to palpation, red stool noted during rectal exam. Dry lips. Skin warm, dry to touch. Air enema reduction of ileocolic intussusception. Subsequent exploratory laparoscopy and reduction of ileoileal intussusception ICD-9 Codes: 560.0 789.00, 789.07, 787.02, 792.1


VAERS ID: 351299 (history)  
Age: 0.58  
Gender: Female  
Location: South Carolina  
Vaccinated:2009-05-28
Onset:2009-06-15
   Days after vaccination:18
Submitted: 2009-07-07
   Days after onset:22
Entered: 2009-07-14
   Days after submission:7
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (PENTACEL) / SANOFI PASTEUR C3224AA / 2 LL / IM
HEP: HEP B (ENGERIX-B) / GLAXOSMITHKLINE BIOLOGICALS AHBVB736AA / 2 RL / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D34438 / 2 LL / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41DA734A / 2 - / PO

Administered by: Private       Purchased by: Public
Symptoms: Intussusception, Surgery
SMQs:, Gastrointestinal obstruction (narrow)

Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: Well check up/constipation
Preexisting Conditions: None 12/10/09 Received medical records w/PMH: hernia repair. Allergies: NKDA
Diagnostic Lab Data: 12/10/09 Received medical records w/Labs: CBC, BMP, UA, Amylase, Lipase, Blood culture, no results noted, stools were guiac +. CXR norm, Air enema + for intussusception.
CDC Split Type:

Write-up: Intussusception requiring surgical reduction. 12/10/2009 Received ED records for 6/16-6/18/2009, DC DX Intussusception which was successively reduced. ICD-9 560.0 patient with c/o''s nausea/vomiting, fever, lethargy, progressive sx x 3 days. Blood per rectum, Tx: IVF, IV ABX, Telemetry. Air enema partially reduced IS & patient transfered to higher level of care. Repeat air enema done.


VAERS ID: 352902 (history)  
Age: 0.39  
Gender: Male  
Location: New York  
Vaccinated:2009-07-24
Onset:2009-07-30
   Days after vaccination:6
Submitted: 2009-07-31
   Days after onset:1
Entered: 2009-07-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (PENTACEL) / SANOFI PASTEUR C3242AA / 0 LL / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D48927 / 1 RL / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41FA802A / 0 - / PO

Administered by: Unknown       Purchased by: Unknown
Symptoms: Enema administration, Intussusception, Urinary system X-ray
SMQs:, Gastrointestinal obstruction (narrow)

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: PMH: None Allergies: NKDA
Diagnostic Lab Data: KUB: findings which suggest an intussusception with the leading edge in the left transverse colon. The air in the right and transverse colon appears to have been displaced and there is what appears to be dilated small bowel in the right upper right quadrant of the abdomen. Air enema: ileo-colo-colic intussusception with satisfactory reduction. Labs none noted Dx studies: Xrays of abdomen + for intussusception, barium enem
CDC Split Type:

Write-up: intussusception 11/18/2009 ED record for 7/30-7/31/2009. DC DX Intussusception Patient with c/o''s irritability, vomiting. Xrays + for intussusception which was reduced per air enema. F/up xrays noted resolution. . ICD-9 code 560.0


VAERS ID: 354417 (history)  
Age: 0.3  
Gender: Male  
Location: Illinois  
Vaccinated:2009-07-30
Onset:2009-08-11
   Days after vaccination:12
Submitted: 2009-08-17
   Days after onset:6
Entered: 2009-08-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTPPHIB: DTP + IPV + ACT-HIB (NO BRAND NAME) / UNKNOWN MANUFACTURER C3237AA / 1 LL / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D48928 / 1 RL / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41FA802A / 1 - / PO

Administered by: Unknown       Purchased by: Unknown
Symptoms: Barium enema, Diarrhoea, Full blood count, Haematochezia, Intussusception, Metabolic function test, Vomiting
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Pseudomembranous colitis (broad), Gastrointestinal obstruction (narrow), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Noninfectious diarrhoea (narrow)

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: none
Preexisting Conditions: none
Diagnostic Lab Data: CBC, BMP, STOOL FOR ROTAVIRUS, Ba ENEMA STUDY. 9/3/09 Hospital records received DOS 8/11/09 to 8/14/2009. LABS and DIAGNOSTICS: Ultrasound Abdomen - Abnormal. X-ray Abdomen - Abnormal. Stool Rotavirus (-). Guaiac (+). CBC - WBC 19.78 /mm3 (H) MCV um3 (L). CHEM - Potassium 6.8 mEq/L (H) Chloride 113 mEq/L (H) Glucose 111 mg/dL (H).
CDC Split Type:

Write-up: THE PATIENT PRESENTED WITH DIARRHEA ON AUG 11, 2209. BECAUSE OF PERSITENT DIARRHEA, PATIENT WENT TO ER AT HOSPITAL AND WAS TRANSFERRED TO ANOTHER HOSPITAL. THE PATIENT WAS WORKED UP AND REHYDRATED. ON DAY 3 OF HOSPITALIZATION,THE PATIENT HAD EMESIS AND BLOODY STOOLS. HE WAS DIAGNOSED AS HAVING INTUSSUSCEPTION AND WAS REDUCED WITH Ba ENEMA. THE PATIENT WAS DISCHARGED NEXT DAY. 9/3/09 Hospital records received DOS 8/11/09 to 8/14/2009. Assessment: Dehydration, Gastroenteritis, Intussusception. Patient was seen at outside ED, given bolus of fluids and transfered. Patient presented on the day of admission with a 2 day history of diarrhea and a one day history of vomiting. Increased output of mucosy blood-tinged stools. Decreased PO intake and urine output, not producing tears, pale. Lethargic. Belly distended and tender. Reduction of intussusception with barium enema. ICD-9 Codes: 276.51 Dehydration, 558.9Y Gastroenteritis, 560.0 Intussusception.


VAERS ID: 354607 (history)  
Age: 0.21  
Gender: Female  
Location: New York  
Vaccinated:2009-07-08
Onset:2009-07-15
   Days after vaccination:7
Submitted: 2009-08-05
   Days after onset:21
Entered: 2009-08-07
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR C3084AA / - UN / UN
IPV: POLIO VIRUS, INACT. (IPOL) / SANOFI PASTEUR B0476 / - UN / UN
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D4687U / - UN / UN
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41OA733A / 0 - / PO

Administered by: Private       Purchased by: Private
Symptoms: Dehydration, Intussusception, Vomiting
SMQs:, Acute pancreatitis (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Gastrointestinal obstruction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: There were no reported concomitant medications or relevant medical history. The subject had not experienced adverse events following previous vaccinations.
Diagnostic Lab Data: UNK. 10/2/09 Hospital records, DC summary, received DOS 7/16/09 to 7/17/09. LABS and DIAGNOSTICS: Ultrasound Abdomen Abnormal. CBC - WBC 14.6 (H) HCT 30.2% (L) MCV 91.1 (L) MCH 31.5 MMG (L) Platelets 454 THO/UL (H) Mono 16% (H) Atyp Lymph 2% (H). CHEM - CL 110 MEQ/L (H) Protein 5.5 GM/DL (L).
CDC Split Type: A0799191A

Write-up: This case was reported by a healthcare professional and described the occurrence of intussusception in a 2-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). There were no reported concomitant medications or relevant medical history. The subject had not experienced adverse events following previous vaccinations. Concurrent vaccination included DAPTACEL (non-gsk) (Sanofi) given on 8 July 2009; PREVNAR (non-gsk) (Wyeth Labs) given on 8 July 2009; IPOL (non-gsk) (Sanofi) given on 8 July 2009. On 8 July 2009 the subject received 1st dose of ROTARIX (1 ml; oral). The lot number was reported as A41OA733A. On 15 July 2009, 7 days after vaccination with ROTARIX, the subject experienced intussusception and "severe" vomiting. The subject was hospitalised and the healthcare professional considered the events were clinically significant (or requiring intervention). At the time of reporting the events were improved. The healthcare professional considered the events were probably related to vaccination with ROTARIX. 10/2/09 Hospital records, DC summary, received DOS 7/16/09 to 7/17/09. Assessment: Intussusception. Presented to ER with 2 days of increased vomiting, fussiness, and decreased stooling, no wet diapers. Fever, respirations and heart rate elevated. Rash below chin. Abdomen rigid. Symptoms resolved with air enema. Some ascites. ICD-9 Codes: 560.0 Intussusception, 276.51 Dehydration. Follow-up information received on 21 August 2009 indicated that the events began on 15 July 2009 and resolving by the following day, 16 July 2009. The subject received an enema for treatment and symptoms resolved. In the reporter''s opinion, the events were probably related to treatment with ROTARIX. The child did not receive bowel resection.


Result pages: 1 2 3 4 5 6 7 8 9 10   next

New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&SYMPTOMS[]=Intussusception+%2810022863%29&VAX[]=RV1&REPORT_YEAR_LOW=2008&REPORT_MONTH_LOW=02&REPORT_YEAR_HIGH=2014&REPORT_MONTH_HIGH=12


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166